Canada Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, and COVID-19 Impact Analysis, By Modality (Computed tomography (CT), X-ray, Ultrasound, Magnetic Resonance Imaging (MRI), and Nuclear Medicine), By Application (Arrhythmia, Heart Attack, Heart Failure, Congenital Heart Conditions, and Other Applications), By End-Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs), and Other End-Users), and Canada Coronary Heart Disease Diagnostic Imaging Devices Market Insights Forecasts 2023 - 2033.

Canada Coronary Heart Disease Diagnostic Imaging Devices Market Insights Forecasts to 2033

• The Canada Coronary Heart Disease Diagnostic Imaging Devices Market Size is Growing at 5.98% CAGR from 2023 to 2033.
• The Canada Coronary Heart Disease Diagnostic Imaging Devices Market Size is Expected to Reach a Significant Share by 2033.

The Canada Coronary Heart Disease Diagnostic Imaging Devices Market Size is expected to reach a significant share by 2033, growing at a 5.98% CAGR from 2023 to 2033.     

Market Overview

The Canada coronary heart disease diagnostic imaging devices market is the business that deals with the manufacturing, production, and sale of imaging equipment for coronary heart disease (CHD) diagnosis in Canada. The market involves technologies such as echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), nuclear imaging, and angiography. These machines assist in identifying, monitoring, and evaluating the severity of CHD through the delivery of precise images of the heart and blood vessels. Market expansion is fueled by improvements in imaging technology, growth in CHD prevalence, and expanding demand for early and accurate diagnosis. The Canada coronary heart disease diagnostic imaging devices market offers promising prospects owing to evolving imaging technology, the growing prevalence of coronary heart disease, and increased demand for timely diagnosis. Deployment of AI-enabled imaging products and mobile diagnostic units increases efficiency and accessibility. Favorable government support for cardiac healthcare and enhanced medical infrastructure investments increase market growth further. Also, growing health awareness regarding preventive healthcare and the growing geriatric population drive the demand for advanced, non-invasive imaging methods, driving the market. As of March 21, 2025, no special government statements are available for the coronary heart disease diagnostic imaging devices market in Canada.

Report Coverage

This research report categorizes the market for the Canada coronary heart disease diagnostic imaging devices market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada coronary heart disease diagnostic imaging devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada coronary heart disease diagnostic imaging devices market.

Driving Factors

The Canada coronary heart disease (CHD) diagnostic imaging devices market is fueled by several key drivers. The growing incidence of coronary heart disease because of aging populations, inactive lifestyles, obesity, and rising rates of hypertension and diabetes is a key growth driver. Since CHD continues to be a major cause of death in Canada, the need for sophisticated diagnostic imaging technology is on the rise. Technological improvements in imaging modalities like cardiac MRI, CT angiography, and nuclear imaging have elevated diagnostic precision and the ability to detect CHD earlier. The incorporation of artificial intelligence (AI) into imaging systems improves accuracy, productivity, and workflow, fueling market growth further. Moreover, increasing demand for minimally invasive diagnostic procedures, which minimize patient distress and recovery time, contributes to increased demand for sophisticated imaging devices. Government programs and health investments in Canada further fuel market growth. More funding for cardiac treatments, increasing awareness initiatives, and healthcare infrastructure development further contribute to increased access to diagnostic imaging services. Moreover, joint efforts between medical device companies and research institutions fuel technological advances in imaging. In addition, increasing the use of handheld and point-of-care imaging machines for faster diagnosis in emergency environments is further stimulating market growth. All these factors collectively drive the strong demand for CHD diagnostic imaging equipment in Canada.

Restraining Factors

Market growth is hindered in the Canada coronary heart disease diagnostic imaging devices market confronts include expensive prices of technologically advanced imaging devices, restricted availability in remote regions, and insufficiency of trained specialists. Strict regulatory clearances, reimbursement issues, and radiation risks all act as impediments to market development and universal uptake of this equipment.

Market Segment

• The computed tomography (CT) segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the modality, the Canada coronary heart disease diagnostic imaging devices market is divided into computed tomography (CT), X-ray, ultrasound, magnetic resonance imaging (MRI), and nuclear medicine. Among these, the computed tomography (CT) segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to its high accuracy in detecting coronary heart disease, non-invasive nature, and rapid imaging capabilities. Technological advancements, increasing adoption of multi-slice CT scanners, and rising coronary disease prevalence are expected to drive significant CAGR growth during the forecast period.

• The heart attack segment accounted for the majority of the share in 2023 and is estimated to grow at a significant CAGR during the projected timeframe.

Based on the application, the Canada coronary heart disease diagnostic imaging devices market is divided into arrhythmia, heart attack, heart failure, congenital heart conditions, and other applications. Among these, the heart attack segment accounted for the majority of the share in 2023 and is estimated to grow at a significant CAGR during the projected timeframe. The segmental growth is attributed to the rising prevalence of cardiovascular diseases, increasing risk factors like hypertension and diabetes, and growing awareness about early diagnosis. Advancements in diagnostic imaging and improved access to healthcare services are expected to drive significant CAGR growth during the forecast period.

• The hospitals segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-use, the Canada coronary heart disease diagnostic imaging devices market is divided into hospitals, diagnostic imaging centers, ambulatory surgical centers (ASCs), and other end-users. Among these, the hospitals segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to the availability of advanced diagnostic imaging devices, skilled healthcare professionals, and comprehensive cardiac care facilities. Increasing hospital admissions for coronary heart disease, rising healthcare infrastructure investments, and the demand for accurate diagnostics are expected to drive significant CAGR growth during the forecast period.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Canada coronary heart disease diagnostic imaging devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Canon Inc.
• Carestream Health
• CHISON Medical Technologies Co., Ltd.
• Esaote SPA
• FUJIFILM Holdings Corporation
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Neusoft Corporation
• Samsung Electronics Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers AG
• Ziehm Imaging GmbH.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at regional, and country levels from 2022 to 2033. Spherical Insights has segmented the Canada coronary heart disease diagnostic imaging devices market based on the below-mentioned segments:

Canada Coronary Heart Disease Diagnostic Imaging Devices Market, By Modality

• Computed Tomography (CT)                 
• X-ray          
• Ultrasound             
• Magnetic Resonance Imaging (MRI)                  
• Nuclear Medicine

Canada Coronary Heart Disease Diagnostic Imaging Devices Market, By Application

• Arrhythmia
• Heart Attack
• Heart Failure                             
• Congenital Heart Conditions
• Other Applications

Canada Coronary Heart Disease Diagnostic Imaging Devices Market, By End-Use

• Hospitals               
• Diagnostic imaging centers
• Ambulatory surgical centers (ASCs)       
• Other end-users